Please login (Members) to view content or (Nonmembers) this article.
No votes yet
Cochrane Nursing Care Field
Histamine Type 2 Receptor Antagonists as Adjuvant Treatment for Resected Colorectal Cancer
CJON 2013, 17(2), 211-212 DOI: 10.1188/13.CJON.211-212
Objective: To assess whether histamine type 2 receptor antagonists (H2RAs) improve overall survival when used as pre-, peri-, or postoperative therapy in patients with colorectal cancer who had surgical resection with curative intent.
Members Only
Access to this article is restricted. Please login to view the full article.